Radiopeptidtherapie - der "Mustang" in der Therapie von neuroendokrinen Tumoren des gastroentero-pankreatischen Systems?

Michael Gabriel

doi:10.1007/s41969-018-0034-7

Radiopeptidtherapie - der "Mustang" in der Therapie von neuroendokrinen Tumoren des gastroentero-pankreatischen Systems?

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	German (Austria)
Pages (from-to)	81-85
Number of pages	5
Journal	Journal für Klinische Endokrinologie und Stoffwechsel
Volume	11
Issue number	3
DOIs	https://doi.org/10.1007/s41969-018-0034-7
Publication status	Published - 2018

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

JKU Focus areas

Medical Sciences (in general)
Health System Research
Clinical Research on Aging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s41969-018-0034-7

Cite this

@article{52666dfd702f4a8a9ef024d277d7cfde,

title = "Radiopeptidtherapie - der {"}Mustang{"} in der Therapie von neuroendokrinen Tumoren des gastroentero-pankreatischen Systems?",

author = "Michael Gabriel",

year = "2018",

doi = "10.1007/s41969-018-0034-7",

language = "Deutsch ({\"O}sterreich)",

volume = "11",

pages = "81--85",

journal = "Journal f{\"u}r Klinische Endokrinologie und Stoffwechsel",

issn = "1998-7781",